Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A E, Moormann"'
3-Methyl-4H-[1,2,4]-oxadiazol-5-one: a versatile synthon for protecting monosubstituted acetamidines
Autor:
Jeffery S. Snyder, James A. Sikorski, Michele A. Promo, Jane L. Wang, Katherine E. Palmquist, Alan E. Moormann, Mark A. Massa, Jeffrey A. Scholten, R. Keith Webber
Publikováno v:
Tetrahedron. 60:10907-10914
The utilization of 3-methyl-4H-[1,2,4]-oxadiazol-5-one as a versatile protected acetamidine is demonstrated through employment in a variety of synthetic sequences. The potassium salt ( 2a ) or the neutral form ( 2b ) is alternatively shown to be supe
Publikováno v:
Tetrahedron. 55:11787-11802
A racemic synthesis of azanoradamantane (±) -3 was accomplished via Yamamoto's MAD-catalyzed Diels-Alder protocol. Subsequently, a scalable asymmetric synthesis of azanoradamantane benzamide SC-52491 was carried out employing Helmchen's asymmetric D
Autor:
Alan E. Moormann
Publikováno v:
Synthetic Communications. 23:789-795
Borane-pyridine complex (BAP) was found to be an excellent replacement for NaCNBH3 in the Borch reduction. Assorted aromatic, heterocyclic and aliphatic aldehydes were reacted with various substituted piperidines using standardized conditions.
Autor:
Ronald Keith Webber, William M. Moore, Pamela T. Manning, Sue Metz, Mihaly V. Toth, Alan E. Moormann, Gina M. Jerome, Donald W. Hansen, Christine Kornmeier, Barnett S. Pitzele
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 11:2651-2653
The potency and selectivity of a series of 5-hetero-2-iminohexahydroazepines were examined as inhibitors of the three human NOS isoforms. The effect of ring substitution of the 5-carbon for a heteroatom is presented. Potencies (IC50's) for these inhi
Autor:
Alan E. Moormann
Publikováno v:
ChemInform. 24
Borane-pyridine complex (BAP) was found to be an excellent replacement for NaCNBH3 in the Borch reduction. Assorted aromatic, heterocyclic and aliphatic aldehydes were reacted with various substituted piperidines using standardized conditions.
Autor:
Alan E. Moormann, Donald W. Hansen, Gina M. Jerome, Sue Metz, Barnett S. Pitzele, Ronald Keith Webber, William M. Moore, Mihaly V. Toth, Pamela T. Manning, Christine Kornmeier
Publikováno v:
ChemInform. 33
The potency and selectivity of a series of 5-hetero-2-iminohexahydroazepines were examined as inhibitors of the three human NOS isoforms. The effect of ring substitution of the 5-carbon for a heteroatom is presented. Potencies (IC50's) for these inhi
Autor:
Maida A. Virina, Dai-Chang Yang, Bela Goldstin, Alan E. Moormann, Daniel L. Flynn, R F Loeffler, G. W. Gullikson
Publikováno v:
Drug Development Research. 26:405-417
Zacopride is an antiemetic agent whose (S) and (R) stereoisomers demonstrate differential pharmacology at 5-HT3 receptors, emphasizing the importance of pharmacologic profiling of each enantiomer of a racemic drug mixture. Characterization of the gas
Autor:
Barnett S. Pitzele, Stella S. Yu, R. G. Bianchi, M. Grebner, B. Rubin, Alan E. Moormann, D. Albin, Peter H. Jones, Gary W. Gullikson, E. L. Sanguinetti
Publikováno v:
Journal of Medicinal Chemistry. 33:614-626
Lofexidine, an alpha 2-agonist, has central hypotensive activity and peripheral intestinal antisecretory activity. Analogues were synthesized with increased polarity in an attempt to prevent penetration of the blood-brain barrier. The compounds were
Autor:
Roger Nosal, Alan E. Moormann, Richard F. Loeffler, Daniel L. Flynn, Gary W. Gullikson, Clara I. Villamil, Daniel P. Becker, Chafiq Moummi, Dai-C Yang
Publikováno v:
Journal of medicinal chemistry. 49(3)
A series of pyrrolizidine esters, amides, and ureas was prepared and tested for 5-HT(4) and 5-HT(3) receptor binding, 5-HT(4) receptor agonism in the rat tunica muscularis mucosae (TMM) assay, and for 5-HT(3) receptor-mediated functional antagonism i
Autor:
D L, Flynn, D P, Becker, V M, Dilworth, M K, Highkin, P J, Hippenmeyer, K A, Houseman, L M, Levine, M, Li, A E, Moormann, A, Rankin, M V, Toth, C I, Villamil, A J, Wittwer, B C, Holwerda
Publikováno v:
Drug design and discovery. 15(1)
The herpesvirus protease is a recently identified enzyme which is essential for viral replication. It is found in all herpesviruses and offers a new molecular target for therapeutic intervention. Its genomic structure has recently been described and